- Home
- SFNC vs VKTX Comparison
SFNC vs VKTX Comparison
Compare SFNC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SFNC | VKTX |
|---|---|---|
| Founded | 1903 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SFNC | VKTX |
|---|---|---|
| Price | $22.51 | $28.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $22.17 | ★ $95.86 |
| AVG Volume (30 Days) | 1.1M | ★ 1.9M |
| Earning Date | 04-16-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,607.90 | N/A |
| Revenue Next Year | $4.15 | N/A |
| P/E Ratio | $47.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.00 | $22.96 |
| 52 Week High | $22.28 | $43.15 |
Technical Indicators
Market Signals| Indicator | SFNC | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.41 | 43.67 |
| Support Level | $18.65 | $25.77 |
| Resistance Level | N/A | $32.92 |
| Average True Range (ATR) | 0.49 | 1.29 |
| MACD | 0.10 | -0.11 |
| Stochastic Oscillator | 92.17 | 30.67 |
Price Performance
Historical ComparisonAbout SFNC Simmons First National Corporation
Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. Its loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.